In this study, HYP as an alternative natural compound specific for stabilizing RyR2 and targeting ER Ca2+, may be a promising agent for AD treatment by impeding the pathogenic cascade induced by Aβ and Ca2+ dyshomeostasis. The gene discussed is RYR2; the disease is Alzheimer disease.